Health care scientific instrument companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Avantor has the lowest figure of the 11 health care scientific instrument companies ranked by P/S ratio, at 1.6, followed by Bruker (2.8) and Bio-Rad Laboratories (3.8). Figures as of 19 Nov 2026, 20:59 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 11
- Lowest
- Avantor1.6
- Median
- 6.5
- Combined market value
- CHF 568.4B
- Countries
- 1
Market values as of .
All countries▾
North America
Scientific instruments▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AvantorAVTR · Health Care | 1.6 | CHF 8.6B | CHF 12.76 | 1.66% down | 40% up | ||
| 2 | BrukerBRKR · Health Care | 2.8 | CHF 8B | CHF 52.43 | 1.79% down | 44% up | ||
| 3 | Bio-Rad LaboratoriesBIO · Health Care | 3.8 | CHF 8.3B | CHF 309.52 | 0.92% down | 22% up | ||
| 4 | Thermo Fisher ScientificTMO · Health Care | 5.7 | CHF 215.7B | CHF 582.06 | 0.44% down | 21% up | ||
| 5 | RevvityRVTY · Health Care | 5.9 | CHF 14.3B | CHF 128.24 | 0.31% down | 62% up | ||
| 6 | DanaherDHR · Health Care | 6.5 | CHF 135.2B | CHF 192.19 | 0.37% down | 3% up | ||
| 7 | IlluminaILMN · Health Care | 7.0 | CHF 25.6B | CHF 169.28 | 4.49% down | 76% up | ||
| 8 | Agilent TechnologiesA · Health Care | 7.1 | CHF 41.8B | CHF 148.24 | 0.94% down | 22% up | ||
| 9 | Mettler-Toledo InternationalMTD · Health Care | 8.4 | CHF 28.6B | CHF 1,439.54 | 1.81% down | 24% up | ||
| 10 | 10x GenomicsTXG · Health Care | 11.7 | CHF 6.4B | CHF 48.42 | 0.53% up | 247% up | ||
| 11 | WatersWAT · Health Care | 28.4 | CHF 75.8B | CHF 385.87 | 1.90% down | 23% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8439 CHF).
Questions and answers
Which health care scientific instrument companies have the lowest P/S ratio?
Avantor (1.6), Bruker (2.8) and Bio-Rad Laboratories (3.8) have the lowest P/S ratio of the 11 health care scientific instrument companies ranked here as of 19 Nov 2026, 20:59 UTC.
How many health care scientific instrument companies are in this ranking?
11 are ranked by P/S ratio.
What are these health care scientific instrument companies worth together?
The 11 health care scientific instrument companies ranked by P/S ratio have a combined market value of CHF 568.4B as of 19 Nov 2026, 20:59 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care scientific instrument companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/category/scientific-instruments?sector=health-care&by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.